1. Home
  2. BBIO vs SCI Comparison

BBIO vs SCI Comparison

Compare BBIO & SCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • SCI
  • Stock Information
  • Founded
  • BBIO 2015
  • SCI 1962
  • Country
  • BBIO United States
  • SCI United States
  • Employees
  • BBIO N/A
  • SCI N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • SCI Other Consumer Services
  • Sector
  • BBIO Health Care
  • SCI Consumer Discretionary
  • Exchange
  • BBIO Nasdaq
  • SCI Nasdaq
  • Market Cap
  • BBIO 9.4B
  • SCI 10.9B
  • IPO Year
  • BBIO 2019
  • SCI N/A
  • Fundamental
  • Price
  • BBIO $51.21
  • SCI $80.09
  • Analyst Decision
  • BBIO Strong Buy
  • SCI Strong Buy
  • Analyst Count
  • BBIO 16
  • SCI 4
  • Target Price
  • BBIO $64.44
  • SCI $90.25
  • AVG Volume (30 Days)
  • BBIO 2.2M
  • SCI 823.9K
  • Earning Date
  • BBIO 11-11-2025
  • SCI 10-29-2025
  • Dividend Yield
  • BBIO N/A
  • SCI 1.60%
  • EPS Growth
  • BBIO N/A
  • SCI 7.63
  • EPS
  • BBIO N/A
  • SCI 3.68
  • Revenue
  • BBIO $235,812,000.00
  • SCI $4,246,591,999.00
  • Revenue This Year
  • BBIO $115.49
  • SCI $3.84
  • Revenue Next Year
  • BBIO $64.61
  • SCI $3.29
  • P/E Ratio
  • BBIO N/A
  • SCI $21.75
  • Revenue Growth
  • BBIO 7.62
  • SCI 2.65
  • 52 Week Low
  • BBIO $21.72
  • SCI $71.75
  • 52 Week High
  • BBIO $54.60
  • SCI $89.37
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 52.92
  • SCI 53.11
  • Support Level
  • BBIO $52.20
  • SCI $76.85
  • Resistance Level
  • BBIO $54.60
  • SCI $80.96
  • Average True Range (ATR)
  • BBIO 2.26
  • SCI 1.46
  • MACD
  • BBIO -0.06
  • SCI 0.05
  • Stochastic Oscillator
  • BBIO 56.48
  • SCI 73.47

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About SCI Service Corporation International

Service Corp International is a personal services company that provides funeral and cemetery services and products from its locations throughout the United States and Canada. The company segments its operations into funeral service and cemetery business functions. At its funeral service locations, Service Corp. provides all professional services, facilities, vehicles, and merchandise related to funerals and cremations. Cemetery locations provide cemetery property, memorial markers, and graveyard services to customers. Service Corp. derives the majority of its revenue from its funeral services segment. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: